Lateral ventricle tumors: Surgical strategies according to tumor origin and development - A series of 72 cases
Lateral ventricle tumors: Surgical strategies according to tumor origin and development - A series of 72 cases
复制标题
DOI:
10.1227/01.neu.0000333772.35822.37
复制
发表时间:
2008-06-01
期刊:
影响因子:
4.8
通讯作者:
Carosi, Illuminato
中科院分区:
文献类型:
--
作者:
D'Angelo, Vincenzo A.;Galarza, Marcelo;Carosi, Illuminato
OBJECTIVE: Optimal surgical management in lateral ventricle tumors remains controversial. We conducted a retrospective study of patients with these lesions treated with a surgical strategy on the basis of tumor origin: primary or secondary ventricular and associated transependymal development.METHODS: A total of 72 patients underwent surgery for lateral ventricle tumors. The mean patient age was 39 years (range, 6 mo to 78 yr). Raised intracranial pressure occurred in 53% of patients, followed by mental disturbances or psychiatric symptoms (32%) and motor deficits (21%). The transcortical approach was used in 44 patients, and an interhemispheric approach was used in 28 patients; a transcallosal approach was used in 16 patients, and a parasplenial approach was used in 12 patients. Neuropsychological tests were performed in selected patients.RESULTS: Total resection was performed in 82% of patients. Sixty-five percent of tumors were benign and low-grade tumors. There was no surgical mortality, and the morbidity rate was 11%. Postoperative epilepsy (5.9%) was significantly increased in the transcortical group. The mean follow-up period was 55 months; 59% of patients achieved good recovery and moderate disability. In postoperative neuropsychological testing sessions, deficits in verbal memory were observed in six patients (8%). Final morbidity correlated well with preoperative clinical condition and pathological diagnosis.CONCLUSION: Lateral ventricle tumors can be treated hest by careful selection of the approach according to tumor origin and development it. Overall, the transcallosal approach is preferred, but in patients with transependymal growth or large primary or secondary ventricular tumors, the transcortical is a better option.